Search results
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 2 days agoNovavax will also receive tiered royalties on sales. Sanofi also made a $70 million investment in...
The 'Impressive' Results That Sent Top 1% Avidity Biosciences To A Record
Investor's Business Daily· 3 days agoAll patients showed reductions greater than 20%. Avidity previously said it would have been happy...
FDA advisors recommend Eli Lilly's Alzheimer's drug donanemab, paving way for approval
CNBC· 5 days agoEli Lilly & Co.'s shares climbed in early US trading after its experimental drug for Alzheimer's...
Sarepta Jumps After Pfizer's Rival Gene Therapy Flops In Phase 3 Test
Investor's Business Daily· 2 days agoBut Sarepta hopes the FDA will allow older and non-ambulatory children to receive the gene therapy....
Avidity Biosciences, Inc. Announces Pricing of Public Offering of Common Stock
The Mammoth Times· 2 days agoAvidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced ...
Eli Lilly Runs Up 49% With Expectations For Weight-Loss Sales To Triple
Investor's Business Daily· 3 days agoRevenue from Eli Lilly's weight-loss drug is expected to triple over the next five years to over $50...
Is Eli Lilly Stock A Buy After FDA Advisors Back Its Alzheimer's Drug?
Investor's Business Daily· 4 days agoBut Zepbound sales shined, bringing in $517.4 million, whereas analysts expected just $373 million....
Eli Lilly Pushes Alzheimer's Stocks Lower On FDA Win
Investor's Business Daily· 4 days agoDespite the stock move, analysts largely expect donanemab to gain FDA approval. Late Monday, the advisors to the FDA voted unanimously that the clinical...
Steward secures $225m financing amid bankruptcy proceedings
Hospital Management via Yahoo Finance· 3 days agoInvestment banking services are being rendered by Lazard Frères & Co., Leerink Partners, and Cain...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 2 days agoAnalysts are closely watching United Therapeutics' pipeline. The company now expects to have the...